Tumor-specific antibodies in sera from patients with squamous cell carcinoma of the uterine cervix
β Scribed by A. W. Linde; M. Streefkerk; E. R. Velde; H. J. Schuurman; B. G. Szabo; L. Kater
- Publisher
- Springer-Verlag
- Year
- 1981
- Tongue
- English
- Weight
- 805 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
β¦ Synopsis
An indirect immunofluorescence assay is described which specifically detects antibodies against cervical carcinoma-associated membrane antigens. Cells from the ME-180 cervical carcinoma cell line were used as target cells. Sera had to be absorbed with pooled tonsillar lymphocytes prior to use, to remove nonspecific antibodies. The antibody was detected in 61 of 74 patients (82%) with invasive squamous cell carcinoma of the uterine cervix and in 5 of 65 controls (8%). A group of 49 patients with early or preneoplastic stages of this tumor (microinvasive carcinoma, carcinome-in-situ, and dysplasia) did not differ from the control group in the incidence of the antibody (5 of 49 patients, 10%). It is concluded that the occurrence of this antibody is specific for cervical carcinoma (P < 0.001). However, the assay cannot be used as a diagnostic marker for preneoplastic stages of this tumor.
π SIMILAR VOLUMES
Correlations between age and several prognostic factors, such as histologic cell type, depth of invasion, intravascular invasion, and lymph node metastases (LNM), were analyzed in squamous cell carcinoma of the cervix (SCC). A total of 380 patients with Stage IB or more advanced SCC underwent radica
The skillful help of Mrs. M. C. de Boer-Bisschops, Mrs. C. Kosterman-Claassen, Mr. R. Lodewijks, and Mrs. U. M. R. Vrij in performing the CEA assay, and of Mrs. A. Graafmans and Mrs. A. J. M. Pieterson-Scholts in collecting and handling the bloodsamples, is gratefully acknowledged.
## Abstract Antibody activity to Herpes simplex virus typeβ1 (HSVβ1) and typeβ2 (HSVβ2) was measured by the indirect hemagglutination (IHA) test in sera from 124 women with squamousβcell carcinoma of the uterine cervix, 46 women with nonβcervical cancer and 116 matched normal women. The typeβspecif
## Abstract ## BACKGROUND Optimal timing of the measurement of serum squamous cell carcinoma (SCC) antigen during radiation therapy (RT) and its significance for predicting the response of cervical carcinoma patients as early as possible remain unknown. ## METHODS Sixtyβthree patients with SCC o